Ambrosia Biosciences | RoundOS

Weekly digest by email

Loading companies…

Ambrosia Biosciences | RoundOS

Weekly digest by email

Funding history

1 round · 1 with disclosed amounts

Announced	Round	Amount	Investors
Mar 31, 2026	Series B	$100M	Blue Owl Healthcare Opportunities — Role not disclosedBoulder Ventures — Role not disclosedBVF Partners — Role not disclosedDeep Track Capital — Role not disclosedJanus Henderson Investors — Role not disclosedRedmile — Role not disclosedSamsara BioCapital — Role not disclosed

Investors

Blue Owl Healthcare OpportunitiesSeries B Boulder VenturesSeries B BVF PartnersSeries B Deep Track CapitalSeries B Janus Henderson InvestorsSeries B RedmileSeries B Samsara BioCapitalSeries B

Coverage

Mar 31, 2026Ambrosia Biosciences · Series B

Similar companies

De¹Building a Financial World Model trained on live market execution dataUndisclosed · Strategic

OwnerProvides an AI-powered technology and marketing platform for local businesses$240M · Series D

AdvisarAI decisioning layer helping retail suppliers measure retail media investment ROI$750K · Pre-Seed

Sources

ambrosiabiosciences.com ↗